SCHEMBL6766142

SCHEMBL6766142

CCCS(=O)(=O)NCCOc1ccc(CCNS(=O)(=O)CCC)cc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 3/20 0.51
HTT P42858 2/20 0.51
ALDH1A1 P00352 5/20 0.50
CA12 O43570 1/20 0.47
CA1 P00915 1/20 0.47
CA2 P00918 1/20 0.47
CA5A P35218 1/20 0.47
CA9 Q16790 1/20 0.47
CA14 Q9ULX7 1/20 0.47
HPGD P15428 1/20 0.46
ADRB2 P07550 1/20 0.46
ADRB1 P08588 1/20 0.46
ADRB3 P13945 1/20 0.46
SMN1; SMN2 Q16637 3/20 0.46
SLC6A9 P48067 1/20 0.45
ACACB O00763 2/20 0.45
TSHR P16473 2/20 0.44
KDM4E B2RXH2 1/20 0.44
HSD17B10 Q99714 1/20 0.44
NPC1 O15118 2/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6759424 0.92 LMNA (0.52) LMNAHTTALDH1A1HPGDADRB2
SCHEMBL6760995 0.88 HTT (0.52) LMNAHTTALDH1A1HPGDSMN1; SMN2
SCHEMBL6565154 0.86 SMN1; SMN2 (0.50) LMNAHTTALDH1A1CA12CA1
SCHEMBL6763747 0.85 ALDH1A1 (0.47) LMNAHTTALDH1A1HPGDSMN1; SMN2
SCHEMBL6574100 0.80 HSD17B10 (0.44) ALDH1A1CA12CA1CA2CA5A
SCHEMBL6563319 0.80 SMN1; SMN2 (0.53) LMNAHTTALDH1A1CA12CA1
SCHEMBL6563391 0.80 MEN1 (0.54) LMNAHTTALDH1A1CA12CA1
SCHEMBL6763718 0.79 KDM4E (0.46) LMNAHTTALDH1A1SMN1; SMN2SLC6A9
SCHEMBL6763723 0.78 GRIA4 (0.53) LMNAHTTALDH1A1CA12CA1
SCHEMBL6766138 0.78 GRIA4 (0.60) LMNAHTTALDH1A1CA12CA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040147612-A1 Sulfonamide derivatives DAVISON JOSHUA ZWICK (US) 2004-07-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040147612-A1 Sulfonamide derivatives GRIN1, GRIN2A, GRIA1 LMNA 4868/4885HTT 1694/4885ALDH1A1 365/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.